Andrew Brohl is an Oncology physician affiliated with University of South Florida. OpenAlex indexes 331 publications with 5,648 citations (h-index 33); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12902 Usf Magnolia Dr
Tampa, FL 336129416
Telephone
813-745-4673Provider last certified this registry record 12 Jan 2026.
Clinical trials
- Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
Sponsor: TuHURA Biosciences, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Deciphera Pharmaceuticals Inc.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20251 payment
- Ethicon US, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
49.5%Kinase inhibitor49.5%Pazopanib Hcl38%Imatinib Mesylate38%Gleevec25%Part D<11 patientsHormonal (systemic)
20.6%l-Thyroxine20.6%Levothyroxine Sodium100%Part D<11 patientsDermatology
15.5%Corticosteroid15.5%Methylprednisolone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2023 per NIH RePORTER. The latest:
- Role of the Chromosome 19 MicroRNA Cluster in Liver Cancers
H. Lee Moffitt Cancer Ctr & Res Inst
FY2023$248,813K08CA255933 - Role of the Chromosome 19 MicroRNA Cluster in Liver Cancers
H. Lee Moffitt Cancer Ctr & Res Inst
FY2022$248,813K08CA255933 - Role of the Chromosome 19 MicroRNA Cluster in Liver Cancers
H. Lee Moffitt Cancer Ctr & Res Inst
FY2021$248,813K08CA255933
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Vogelbaum, MD
University of South Florida
Thomas Casale, MD
University of South Florida
Richard Lockey, MD
University of South Florida
Robert Hauser, MD
University of South Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”